Background {#S0001}
==========

In pregnant women with gestational diabetes mellitus (GDM), the overall cesarean section rate was accounted for 35.3%.[@CIT0001] Simultaneously, compared with nondiabetic pregnant women, diabetic maternal acute cesarean section rate was reported 1.52 times of GDM.[@CIT0002] Diabetes is an important risk factor for surgical incision infection,[@CIT0003] and for cesarean section, diabetes is an important risk factor for maternal postoperative wound infection as well.[@CIT0004] Thus, the pregnancy with diabetes and the management of special risk factors are important, and the existing systematic evaluation shows that effective treatment and control of GDM can reduce preeclampsia, shoulder dystocia, and the incidence of huge children.[@CIT0005] In addition, several systematic reviews have concentrated on the effects of certain specificc factors based on the health outcomes of pregnant women with GDM, such as the effects of different glycemic management regimens on glycemic control and maternal and child outcomes,[@CIT0006]--[@CIT0010] and effects of dietary intervention or nutritional therapy based on maternal and child outcomes.[@CIT0011],[@CIT0012] For patients with cesarean section with GDM, there have been several studies evaluating differences in patients' outcomes under different conditions, such as anesthesia,[@CIT0013]--[@CIT0015] postoperative fluid regimen,[@CIT0016],[@CIT0017] and postoperative wound care.[@CIT0018] However, there is no systematic review regarding the current evaluation of the factors affecting the maternal and child's outcomes during the period of affecting by GDM. This study was designed to assess the risk factors associated with perioperative outcomes in pregnant women with GDM.

Methods {#S0002}
=======

Inclusion and exclusion criteria {#S0002-S2001}
--------------------------------

Inclusion criteria: 1) pregnant women suffered cesarean section with GDM; 2) exposure factors for cesarean outcomes; 3) RCTs; and 4) reported perioperative outcomes, such as blood glucose level, Apgar scores, adverse effects, and so on. Exclusion criteria: 1) there were no specific outcome data to assess the impact of exposure factors on patients with perioperative outcomes; 2) non-English and Chinese published research, 3) summary of unpublished meeting.

Literature search {#S0002-S2002}
-----------------

We conducted a systematic search on Medline (via PubMed), EMBASE, Cochrane Library, CBM, CNKI and Wanfang, using the terms Diabetes, Gestational, Diabet\*, "Cesarean Section", caesarean, "diabetes, pregnancy", "gestational diabetes mellitus", "cesarean section", "cesarean section", "caesarean section". The retrieval date was February 28, 2018.

Study screening {#S0002-S2003}
---------------

Two researchers independently screened the literature titles, abstracts, and the full text. A pre-test was performed prior to formal screening of the literature to ensure that each researcher truly perceived the screening criteria and process. Discrepancies between the two reviewers were resolved by consensus discussion.

Data extraction {#S0002-S2004}
---------------

The two researchers independently extracted the following data from the pre-designed information extraction table: year of publication, name of journal, the first author's affiliation, place and duration of study, funding, conflict of interest, type of study, sample size, basic characteristics of study object, exposure factors, and associated outcome data. A pretest was conducted before formal extraction to ensure that each researcher agrees with the extraction criteria and process. If there are some differences, they could be solved through discussion.

Risk of bias assessment {#S0002-S2005}
-----------------------

Two researchers used the Cochrane risk of bias tool was used for bias risk assessment of randomized controlled trials. A pretest was conducted before the formal evaluation to ensure that each researcher agrees with the evaluation criteria and process. In case of existence of some differences, they could be solved by a third researcher.

Data consolidation and analysis {#S0002-S2006}
-------------------------------

In the RevMan 5.3 software, the RR and 95% CI were used to combine the binary data, and the data were merged using the mean difference (MD) and 95% CI. The data combination uses a random-effect model. The heterogeneity was included in the study by Cochran's Q test (*P*\<0.05 denotes heterogeneity) and *I*^2^ test. When the number of inclusion indicators is ≥10, the publication bias is evaluated by making a funnel plot; conversely, the qualitative analysis was included in the study funding, the conflict of interest, and the outcome to discuss the possibility of publication bias.

Quality of evidence {#S0002-S2007}
-------------------

The quality of the evidence was graded according to the principles of the GRADE approach used in the evaluation of prognostic studies[@CIT0019],[@CIT0020] and in a previous study (as example).[@CIT0021] (These factors may lead to rating down the quality of evidence in GRADE system) and the three upgraded factors (large effect, dose-response, and plausible confounders) to determine the final level of evidence. Quality of evidence was ranked as high, medium, low, and very low-level using the results of summary table.

Evidence mapping {#S0002-S2008}
----------------

Excel 2016 was used to integrate the RR value from meta-analysis and GRADE. The result is shown intuitively with the bubble diagram. Due to heterogeneity of MD for the outcome, we did not make a bubble diagram for MD value from meta-analysis.

Results {#S0003}
=======

Study selection {#S0003-S2001}
---------------

There are 13,447 articles identified by literature search. After duplicates were removed in endnote, 11,585 records titles and abstractswere reviewed, 142 articles were retrieved full-text reviewing. Finally, a total of 12 randomized controlled trials[@CIT0014],[@CIT0016]--[@CIT0018],[@CIT0022]--[@CIT0029] involving 1,390 patients were included for meta-analysis ([Figure 1](#F0001){ref-type="fig"}).Figure 1The screening flow chart.

Characteristics of the included studies {#S0003-S2002}
---------------------------------------

The studies were published in 2010 and 2017, the sample sizes ranged from 33 to 201. All studies were from China. The participant age was from 24 to 39. The two studies[@CIT0016],[@CIT0023] were funded by nonprofit funds, one study reported that there was not the conflict of interest, and the rest of the study did not report funding ([Table 1](#T0001){ref-type="table"}).Table 1Basic characteristics of included studiesYearCountryFundingConflict of interestTime of researchSample sizePrognostic factorsExposed group (Mean±SD)Nonexposed group (Mean±SD)AgeWeight (kg)Gestation (weeks)AgeWeight (kg)Gestation (weeks)Li 2010[@CIT0025]2010China○○2007.1\~2009.1248Insulin pumpRange: 24\~36○○Range: 24\~36○○Feng 2017[@CIT0027]2017China○○2015.4\~2015.9162Short-term fasting and water-deprivation32.91±4.00○38.74±1.544.07±4.39○38.28±1.47Wang 2017[@CIT0028]2017China○○2014.1\~2016.2110Individual health education○○○○○○Wang 2010[@CIT0016]2010China●^a^○2009.2\~2010.370Fructose Injection○○○○○○Zhao 2011[@CIT0024]2011China○○2011.3\~2011.733PCEA29.7±3.776.7±6.3○30.1±4.177.2±6.2○Yu 2014[@CIT0017]2014China○○2011.5\~2013.10201Fructose Injection31.8±6.9○38.8±1.931.8±6.9○38.8±1.9Chen 2015[@CIT0018]2015China○○2012.9\~2013.9140Microwave treatment for postoperative wound26.4±2.9○○26.4±2.9○○Han 2015[@CIT0022]2015China○○2012.2\~2014.1153Psychological intervention25.13±5.24○26.05±0.2325.13±5.24○26.05±0.23Li 2015[@CIT0023]2015China●^b^○2014.1\~2015.5200Psychological intervention30.05±2.51○○29.03±1.56○○Yin 2015[@CIT0014]2015China○○2014.3\~2015.354Epidural anesthesia28.1±5.4○37.9±5.129.0±5.4○38.5±5.4Zhang 2015[@CIT0026]2015China○○2012.3\~2013.1299Low dose sufentanil combined with bupivacaine VS bupivacaine30.7±2.178.2±8.137.8±1.030.2±2.077.7±7.338.1±0.9Yang 2017[@CIT0029]2017China○○2016.2\~2017.6120Addition of once antibiotic27.2±3.25○○29.1±4.03○○[^2][^3]

Risk of bias for included studies {#S0003-S2003}
---------------------------------

The included RCTs were only low risk of bias in incomplete outcome data and selective reporting ([Figure 2](#F0002){ref-type="fig"}); 8 studies[@CIT0014],[@CIT0017],[@CIT0018],[@CIT0024]--[@CIT0026],[@CIT0029] did not report random sequences; 1 study[@CIT0027] reported that there was a high risk of bias in random sequences; none of the studies reported allocation concealment; 6 studies[@CIT0016],[@CIT0018],[@CIT0026]--[@CIT0029] did not blind the researchers and patients, and they likely contained an impact on the results; 8 studies[@CIT0014],[@CIT0018],[@CIT0022]--[@CIT0026],[@CIT0029] did not blind the outcome evaluators, and they likely contained an influence on the results.Figure 2 Risk of bias graph.

Prognostic factors {#S0003-S2004}
------------------

### Insulin pump {#S0003-S2004-S3001}

One randomized controlled study[@CIT0025] reported a total of 3 outcomes. It was revealed that duration of treatment process (MD=−5.30, 95% CI: −5.78\~−4.82, *P*\<0.00001), insulin dosage (MD=17.00, 95% CI: −23.04\~−10.96, *P\<*0.00001), and the incision healing duration (MD=−4.40, 95% CI: −5.58\~−3.22, *P*\<0.00001) of the repeated subcutaneous injection for insulin group were superior to those of the insulin pump group, and the difference was statistically significant ([Appendix 1](https://www.dovepress.com/get_supplementary_file.php?f=188293-appendix-1.docx)).

### Short-term fasting and water deprivation {#S0003-S2004-S3002}

One randomized controlled study[@CIT0027] reported a total of 11 outcomes. Preoperative blood glucose concentrations (MD=0.84, 95% CI: 0.42\~1.26, *P*=0.001) and the level of blood glucose in newborn infants after birth (MD=0.45, 95% CI: −0.03\~0.87, *P*=0.038) for short-term group were superior to those of long-term group, and the difference was statistically significant. Bleeding volume during cesarean section (MD=−42.71, 95% CI:−82.55\~−2.86, *P*=0.039) for short-term group was inferior to long-term group, and the difference was statistically significant. There were no significant differences in postoperative blood sugar concentrations, the rates of nausea and vomiting, incidence of hypoglycemia in newborn infants after birth and mothers before cesarean section, duration of anus exhausting of puerpera, Apgar score 1 and 5 mins after delivery ([Appendix 1](https://www.dovepress.com/get_supplementary_file.php?f=188293-appendix-1.docx)).

### Individual health education {#S0003-S2004-S3003}

A randomized controlled study[@CIT0028] reported a total of 4 outcomes. Control rates for 2 hr plasma glucose (PG) (RR=1.31, 95% CI: 1.04\~1.66, *P*\<0.05) and midnight blood glucose (RR=1.23, 95% CI: 1.01\~1.50, *P*\<0.05) and the satisfaction rate of nursing services (MD=6.51, 95% CI: 5.80\~7.22, *P\<*0.01) for individualized health education group were superior to those of conventional health education group, and the difference was statistically significant. There were no significant differences in control rates of fasting blood glucose (FBG) as well ([Appendix 1](https://www.dovepress.com/get_supplementary_file.php?f=188293-appendix-1.docx)).

### Fructose injection {#S0003-S2004-S3004}

Two randomized controlled trials[@CIT0016],[@CIT0017] reported a total of 8 outcomes. The blood glucose levels 1.5--2 hours after infusion (MD=−1.17, 95% CI: −1.93\~−0.41, *P*=0.003), blood glucose levels 3--4 hours after infusion (MD=−0.99, 95% CI: −1.61−0.36, *P*=0.002), the level of insulin 1.5 hours after infusion (MD=−13.50, 95% CI: −19.02\~−7.98) (*P*\<0.00001), and the level of insulin 3 hours after infusion (MD=−8.59, 95% CI: −13.75\~−3.43, *P*=0.001) for fructose injection were superior to glucose and Insulin injection. The difference was statistically significant. There were no significant differences in blood glucose level, blood glucose level, urinary carcass positive rate, and urine sugar positive rate after transfusion, and no significant difference was found between the two groups ([Appendix 1](https://www.dovepress.com/get_supplementary_file.php?f=188293-appendix-1.docx)).

### Patient-controlled epidural analgesia (PCEA) {#S0003-S2004-S3005}

A randomized controlled trial[@CIT0024] reported a total of 13 outcomes. The level of blood glucose in presence of analgesia after 6 hours (MD=−0.80, 95% CI: −1.01 to −0.59, *P*\<0.00001), 12 hours (MD=−0.76, 95% CI: −1.00 to −0.52, *P*\<0.00001), 24 hours (MD=−0.65, 95% CI: −0.87 to −0.43, *P*\<0.00001), and 36 hours (MD=−0.75,95% CI: −0.96\~−0.54, *P*\<0.00001) for the patient-controlled intravenous analgesia (PCIA) group was superior to PCIA group. The difference was statistically significant. There was no significant difference between the two groups ([Appendix 1](https://www.dovepress.com/get_supplementary_file.php?f=188293-appendix-1.docx)).

### Microwave treatment for postoperative wound {#S0003-S2004-S3006}

A randomized controlled trial[@CIT0018] reported a outcome (RR=1.15, 95% CI: 1.03\~1.29, *P*=0.01, see Appendix 1, in which the difference was statistically significant (*P*\<0.01) ([Appendix 1](https://www.dovepress.com/get_supplementary_file.php?f=188293-appendix-1.docx)).

### Psychological intervention (including music therapy) {#S0003-S2004-S3007}

Two randomized controlled trials[@CIT0022],[@CIT0023] reported a total of 14 outcome indicators, in addition to entering the operating room immediately with heart rate (MD=−0.86, 95% CI: −2.69\~0.97, *P*=0.36), entering the operating room immediately with anxiety score (MD=−0.13, 95% CI: −2.57\~2.31, *P*=0.92), and the normal feeding rate (RR=1.07, 95% CI: 0.99--1.16, *P*=0.09). The difference between the two groups was not statistically significant. The rest of the outcome indicators for the psychological intervention group were inferior to the conventional nursing group, and the difference between the two groups was statistically significant ([Appendix 1](https://www.dovepress.com/get_supplementary_file.php?f=188293-appendix-1.docx)).

### Epidural anesthesia {#S0003-S2004-S3008}

A randomized controlled trial[@CIT0014] reported a total of six outcomes: glucose concentration at the of cutting skin (MD=1.48, 95% CI: 1.31\~1.65, *P*\<0.00001, 2 hours after delivery (MD=0.90, 95% CI: 0.71 to 1.09, *P*\<0.00001) and 6 hours after delivery (MD=1.11, 95% CI: 0.93 to 1.29, *P*\<0.00001), the epidural group were higher than the general anesthesia group, and the difference was statistically significant. The differences in the other outcomes between the two groups were not statistically significant ([Appendix 1](https://www.dovepress.com/get_supplementary_file.php?f=188293-appendix-1.docx)).

### Low-dose sufentanil combined with bupivacaine of spinal-epidural anesthesia {#S0003-S2004-S3009}

One randomized controlled study[@CIT0026] reported a total of 11 outcomes. Based on the report, glucose concentration at the time of cutting skin (MD=−1.45, 95% CI: −1.61\~−129, *P*\<0.00001), the blood glucose concentration 2 hours after delivery (MD=−0.89, 95% CI: −1.07\~−071, *P*\<0.00001), and the mean arterial pressure 5 mins after anesthesia (MD=5.80, 95% CI: 3.12\~8.48, *P*\<0.00001) were assessed. The difference was statistically significant. However, the differences for the other outcome indicators between the two groups were not statistically significant ([Appendix 1](https://www.dovepress.com/get_supplementary_file.php?f=188293-appendix-1.docx)).

### Addition of once antibiotic {#S0003-S2004-S3010}

One randomized controlled study[@CIT0029] reported a total of 12 outcomes. The treatment efficiency (RR=0.68, 95% CI: 0.04\~1.66, *P*\<0.05) of the addition of an antibiotic once group was inferior to 24 hours antibiotic application group, and the difference was statistically significant. There were no significant differences in response rate, overall response rate, the inefficiency rate, the duration of WBC \<12×10^9^/L, body temperature (without fever or returned to normal status 2 hours after surgery), and the grades A, B, and C of healing ([Appendix 1](https://www.dovepress.com/get_supplementary_file.php?f=188293-appendix-1.docx)).

Publication bias {#S0003-S2005}
----------------

The number of studies included in every outcome was \<10; thus, it was unattempted to use funnel plot to assess the publication bias. All studies have not reported conflict of interest, and only 2 studies reported that the funding originated from the nonprofit grants.

Quality of evidence {#S0003-S2006}
-------------------

The levels of evidence for all the outcome all is low on the GRADE system (see [Appendix 2](https://www.dovepress.com/get_supplementary_file.php?f=188293-appendix-2.docx)). The reasons for downgrading includes the risk of bias (no randomized sequence generation and allocation concealment, no blindness to researchers, patients and outcome evaluators) and inaccuracy (sample size is less than the optimal sample size and the confidence interval of the combined results cross invalid line).

### Evidence mapping {#S0003-S2006-S3001}

Each bubble corresponds to one outcome for the prognostic factors. The size, color, and position of the bubbles were used to indicate the current research status. The size of the bubbles indicates the sample size, and the color of the bubbles indicates the quality of the evidence. The horizontal coordinate indicates the prognostic factors, the vertical coordinate indicates the RR of meta-analysis ([Figure 3](#F0003){ref-type="fig"}).Figure 3Summary of risk ratio and quality of evidence of outcomes for the prognostic factors with the bubble diagram.**Abbreviation:** PCEA, patient-controlled epidural analgesia.

Discussion {#S0004}
==========

The International Federation of Gynecology and Obstetrics (FIGO) guideline recommended to receive cesarean section to prevent shoulder dystocia or birth injury, when fetal weight would be\>4,000 g.[@CIT0030] For pregnant women with cesarean section, in addition to the conventional perinatal management, the integration of perioperative management is required, including blood sugar control, anesthesia, healthcare, etc. This study is the first systematic review of the prognostic factors. The results of the systematic review show that the perioperative blood glucose management regimens, preoperative fasting and water-deprivation regimens, anesthesia regimens, postoperative regimens, postoperative analgesia regimens, postoperative wound care regimens, psychological interventions, and different dosing regimens for antibiotics may affect the health outcomes of diabetic maternal and newborns. However, the quality of evidence was low, and more high-quality clinical research evidence is required.

According to the principle of GRADE method in the evaluation of a prognosis research system,[@CIT0010],[@CIT0011] the quality of evidence for each outcome is low, and the reason of downgrading is mainly bias risk and inaccuracy. The bias risks included in the randomized controlled trials were assessed by the Cochrane Bias Risk Assessment Tool, in which the main source of bias was the nonreported random sequence generation and allocation concealment, which did not blind the researchers, the patients, and the outcome evaluators, and did not report the source of the information and the method of recruiting or joining the patients. The reason for the imprecision is that the sample size is less than the optimal sample size, and the CI of the effect sizes spans the invalid line. For publication bias, as the number of included studies was \<10, the publication bias was not evaluated using a funnel plot. In addition, the included studies did not report the conflict of interest, considering the research topics and manufacturers that may be the interests of the relationship, and in addition to psychological intervention and obesity factors, the rest of the comparison groups were assessed by the possibility of publication bias. However, it was not possible to quantify the possibility of publication bias; thus, the publication bias was not considered in this study. In addition, because most of outcomes included only 1 study, a few outcomes included only 2 studies, and I^2^ values are small, it is not been downgraded due to heterogeneity. We performed meta-analyses by using the random effects model for multiple risk factors and outcomes. The qualities of the evidence for all outcomes were low. As the number of studies increases and the quality of the research improves, new research data may change the results of this system review. Therefore, it needs to more new high-quality research to update the review in the future.

The main advantages of this systematic review are: 1) for the first time on the impact of pregnancy in patients with diabetes maternal--perinatal outcome of the perioperative factors were evaluated; 2) the original research carried out a systematic, comprehensive search, greatly reducing the possibility of missing; 3) the quality of evidence was graded by GRADE method, and the factors affecting the outcome of perioperative period of cesarean section in pregnant women with diabetes mellitus were clearly presented and interpreted. The limitations of the system review: 1) Only the studies published in Chinese and English were searched, the other languages were not be considered; 2) All the studies are from China, the results may not been applied to other countries and regions.

Conclusion {#S0005}
==========

Low-quality evidence shows that perioperative blood glucose management regimens, anesthesia regimens, postoperative fluid regimens, postoperative analgesia regimens, postoperative wound care, and psychological interventions may affect the health outcomes of diabetic maternal and newborns.

This review was supported by Beijing Municipal Science and Technology Commission (Project no. D141107005314004).
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Appendix 1.Effect evaluation resultsOutcomeNo. ofstudiesNo. ofparticipantsEffect estimateRR/MD (95%CI)*P* valueInsulin pump VS multiple subcutaneous injections of insulinBlood glucose standard time (d)148**MD: -5.30 (-5.78, -4.82)**\<0.00001Dose of insulin (U/d)148**MD: -17.00 (-23.04, -10.96)**\<0.00001Surgical incision healing time /d148**MD: -4.40 (-5.58, -3.22)**\<0.00001Fasting and water-deprivation: short-term VS long-termPreoperative blood glucose (mmol/L)1162**MD: 0.84 (0.42, 1.26)**0.001Postoperative blood glucose(mmol/L)1162MD: 0.16 (-0.17, 0.49)0.345Incidence of nausea1162RR: 2.98 (0.77, 11.51)0.180Incidence of vomiting1162RR: 2.24 (0.38, 13.03)0.647Incidence of neonatal hypoglycemia1162RR: 0.25 (0.03, 2.02)0.302Incidence of preoperative hypoglycemia1162RR: 0.54 (0.18, 1.63)0.264Maternal anal discharge time(h)1162MD: -0.04 (-0.25, 0.17)0.692Bleeding during childbirth (ml)1162**MD: -42.71 (-82.55, -2.86)**0.039Neonatal Apgar scores at 1 min1162MD: 0.03 (-0.18, 0.24)0.918Neonatal Apgar scores at 5 min1162MD: -0.03 (-0.14, 0.08)0.183Postnatal blood glucose (mmol/L)1162**MD: 0.45 (0.03, 0.87)**0.038Health education: individualization VS conventionFasting blood glucose compliance rate1110RR: 1.08 (0.86, 1.35)\>0.05Glucose-target-rate at 2 o'clock1110**RR: 1.31 (1.04, 1.66)**\<0.05Glucose-target-rate at 0 o'cl1110**RR: 1.23 (1.01, 1.50)**\<0.05Nursing service satisfaction1110**MD: 6.51 (5.80, 7.22)**\<0.01Fructose Injection VS Glucose Injection + InsulinBlood glucose level at 1.5\~2h after infusion (mmol/L)2202**MD: -1.17 (-1.93, -0.41)**0.003Blood glucose level at 3\~4h after infusion (mmol/L)2202**MD: -0.99 (-1.61, -0.36)**0.002Blood glucose level at 6h after infusion (mmol/L)170MD: -0.62 (-1.86, 0.61)0.32Insulin level at 1.5h after infusion (mU/L)1132**MD: -13.50 (-19.02, -7.98)**\<0.00001Insulin level at 3h after infusion (mU/L)1132**MD: -8.59 (-13.75, -3.43)**0.001Blood uric acid level at 3h after infusion (μmol/L）1132MD: -8.00 (-34.96, 18.96)0.56Positive rate of urine carcass2202RR: 1.14 (0.49, 2.64)0.77Positive rate of urine glucose170RR: 0.21 (0.01, 4.25)0.31PCEA VS PCIABlood glucose level at 3h after the onset of analgesia (mmol/L)133MD: 0.01 (-0.21, 0.23)0.93Blood glucose level at 3h after the onset of analgesia (mmol/L)133**MD: -0.80 (-1.01, -0.59)**\<0.00001Blood glucose level at 12h after the onset of analgesia (mmol/L)133**MD: -0.76 (-1.00, -0.52)**\<0.00001Blood glucose level at 24h after the onset of analgesia (mmol/L)133**MD: -0.65 (-0.87, -0.43)**\<0.00001Blood glucose level at 36h after the onset of analgesia (mmol/L)133**MD: -0.75 (-0.96, -0.54)**\<0.00001VAS score at 36h after the onset of analgesia (mmol/L)133MD: -0.04 (-0.31, 0.23)0.77VAS score at 6h after the onset of analgesia (mmol/L)133MD: -0.01 (-0.20, 0.18)0.92VAS score at 12h after the onset of analgesia (mmol/L)133MD: -0.02 (-0.24, 0.20)0.86VAS score at 24h after the onset of analgesia (mmol/L)133MD: -0.05 (-0.39, 0.29)0.77VAS score at 36h after the onset of analgesia (mmol/L)133MD: -0.04 (-0.35, 0.27)0.80Satisfaction rate of analgesic effect133RR: 1.00 (0.89, 1.12)1.00Vausea and vomiting133RR: 0.31 (0.01, 7.21)0.47Uroschesis133RR: 2.83 (0.12, 64.89)0.51Postoperative wound care: microwave treatment of VS routine careWound healing rate at first stage1140RR: 1.15 (1.03, 1.29)0.01Psychological intervention (including music therapy) VS routine careSystolic pressure immediately into the operating room (mmHg)1200**MD: -9.80 (-12.42, -7.18)**\<0.00001Systolic pressure after surgery into the operating room 30min (mmHg)1200**MD: -35.37 (-38.32, -32.42)**\<0.00001Intraoperative systolic pressure (mmHg)1153**MD: -22.63 (-27.24, -18.02)**\<0.00001Diastolic pressure immediately into the operating room (mmHg)1200**MD: -3.58 (-5.20, -1.96)**\<0.00001Diastolic pressure after surgery into the operating room 30min (mmHg)1200**MD: -7.58 (-9.62, -5.54)**\<0.00001Intraoperative diastolic pressure (mmHg)1153**MD: -10.61 (-14.65, -6.57)**\<0.00001Heart rate immediately into the operating room1200MD: -0.86 (-2.69, 0.97)0.36Heart rate after surgery into the operating room 30min1200**MD: -8.89 (-10.52, -7.26)**\<0.00001Anxiety score immediately into the operating room1200MD: -0.13 (-2.57, 2.31)0.92Anxiety score after surgery into the operating room 30min1200**MD: -2.22 (-3.55, -0.89)**0.001Intro-operative hemorrhage (ml）1153**MD: -62.39 (-78.31, -46.47)**\<0.00001Postoperative morbidity1153**RR: 0.35 (0.19, 0.64)**0.0008Postoperative pains1153**RR: 0.73 (0.60, 0.89)**0.002Postoperative normal feeding1153RR: 1.07 (0.99, 1.16)0.09Epidural anesthesia vs general anesthesiaBlood glucose while skin cutting (mmol/L)154**MD: 1.48 (1.31, 1.65)**\<0.00001Blood glucose while delivery of the fetus (mmol/L)154MD: 0.00 (-0.17, 0.17)1.00Blood glucose while delivery of placenta(mmol/L)154**MD: -0.19 (-0.37, -0.01)**0.04Blood glucose about 2 hours after delivery of the fetus (mmol/L)154**MD: 0.90 (0.71, 1.09)**\<0.00001Blood glucose about 6 hours after delivery of the fetus (mmol/L)154**MD: 1.11 (0.93, 1.29)**\<0.00001Apgar scores \<7154RR: 0.20 (0.01, 3.98)0.29Combined spinal and epidural analgesia: low dose sufentanil combined with bupivacaine VS bupivacaineBlood glucose while skin cutting (mmol/L)166**MD: -1.45 (-1.61, -1.29)**\<0.00001Blood glucose while delivery of the fetus (mmol/L)166MD: 0.01 (-0.13, 0.15)0.89Blood glucose about 5 min after delivery of placenta (mmol/L)166**MD: 0.23 (0.06, 0.40)**0.009Blood glucose about 2 h after delivery of the fetus (mmol/L)166**MD: -0.89 (-1.07, -0.71)**\<0.00001Mean arterial pressure at 1min after anesthesia (mmHg)166MD: 0.40 (-2.11, 2.91)0.75Mean arterial pressure at 2 min after anesthesia (mmHg)166MD: 1.40 (-1.62, 4.42)0.36Mean arterial pressure at 5 min after anesthesia (mmHg)166**MD: 5.80 (3.12, 8.48)**\<0.00001Mean arterial pressure at 10 min after anesthesia (mmHg)166MD: 0.30 (-2.47, 3.07)0.83Mean arterial pressure at 20 min after anesthesia (mmHg)166MD: 1.90 (-1.10, 4.90)0.21Apgar score at 1 min166MD: 0.10 (-0.17, 0.37)0.46Apgar score at 5 min166**MD: 0.10 (0.02, 0.18)**0.01Additional an antibiotic once vs. 24-h antibiotic applicationMarked effective rate1120**RR: 0.68 (0.48, 0.97)**\<0.05Effective rate1120RR: 1.50 (0.97, 2.33)\>0.05Inefficient rate1120RR: 2.00 (0.38, 10.51)\>0.05Total effective rate1120RR: 0.97 (0.89, 1.05)\>0.05WBC\<12×10^9^/L time (d)1120MD: 0.50 (-0.02, 1.02)\>0.05Body temperature (no fever and return to normal 48 h after surgery)1120RR: 0.98 (0.93, 1.04)\>0.05Class-A healing rate1120RR: 0.97 (0.89, 1.05)\>0.05Class-B healing rate1120RR: 2.00 (0.38, 10.51)\>0.05Class-C healing rate1120-\>0.05[^4] Appendix 2.Summary of EvidenceOutcomesNo of participants(studies) Follow-upQuality of the evidence(GRADE)Relative effect (95% CI)Anticipated absolute effectsRisk with control groupRisk difference with observation groupInsulin pump VS multiple subcutaneous injections of insulinBlood glucose standard time (d)48 (1 RCT)LOW ^1,2^\--**MD5.3 fewer(5.78 fewer to 4.82 fewer)**Dose of insulin (U/d)48 (1 RCT)LOW ^1,2^\--**MD17 fewer(23.04 fewer to 10.96 fewer)**Surgical incision healing time /d48 (1 RCT)LOW ^1,2^\--**MD 4.4 fewer(5.58 fewer to 3.22 fewer)**Fasting and water-deprivation: short-term VS long-termPreoperative blood glucose (mmol/L)162 (1 RCT)LOW ^1,2^\--**MD0.84 more(0.42 more to 1.26 more)**Postoperative blood glucose(mmol/L)162 (1 RCT)LOW ^1,5^\--MD 0.16 more(0.17 fewer to 0.49 more)Incidence of nausea162 (1 RCT)LOW ^1,5^RR 2.98(0.77 to 11.51)62 per 1,00015 more per 1,000(61 fewer to 152 more)Incidence of vomiting162 (1 RCT)LOW ^1,5^RR 2.24(0.38 to 13.03)21 per 1,00026 more per 1,000(13 fewer to 248 more)Incidence of neonatal hypoglycemia162 (1 RCT)LOW ^1,5^RR 0.25 (0.03 to 2.02)62 per 1,00047 fewer per 1,000(60 fewer to 63 more)Incidence of preoperative hypoglycemia162 (1 RCT)LOW ^1,5^RR 0.54 (0.18 to 1.63)113 per 1,00052 fewer per 1,000(93 fewer to 71 more)Maternal anal discharge time(h)162 (1 RCT)LOW ^1,5^\--MD 0.04 fewer(0.25 fewer to 0.17 more)Bleeding during childbirth (ml)162 (1 RCT)LOW ^1,2^\--**MD 42.71 fewer(82.55 fewer to 2.86 fewer)**Neonatal Apgar scores at 1 min162 (1 RCT)LOW ^1,5^\--MD 0.03 more(0.18 fewer to 0.24 more)Neonatal Apgar scores at 5 min162 (1 RCT)LOW ^1,5^\--MD 0.03 fewer(0.14 fewer to 0.08 more)Postnatal blood glucose (mmol/L)162 (1 RCT)LOW ^1,5^\--MD 0.45 more(0.03 fewer to 0.87 more)Health education: individualization VS conventionFasting blood glucose compliance rate110 (1 RCT)LOW ^1,5^RR 1.08(0.86 to 1.35)764 per 1,00061 more per 1,000(107 fewer to 267 more)Glucose-target-rate at 2 o'clock110 (1 RCT)LOW ^1,2^**RR 1.31(1.04 to 1.66)**836 per 1,000**259 more per 1,000(33 more to 552 more)**Glucose-target-rate at 0 o'cl110 (1 RCT)LOW ^1,2^**RR 1.23(1.01 to 1.50)**873 per 1,000**201 more per 1,000(9 more to 436 more)**Nursing service satisfaction110 (1 RCT)LOW ^1,2^\--**MD6.51 more(5.80 more to 7.22 more)**Fructose Injection vs. Glucose Injection + InsulinBlood glucose level at 1.5\~2 h after infusion (mmol/L)202 (2 RCTs)LOW ^2,3^\--**MD1.17 fewer(1.93 fewer to 0.41 fewer)**Blood glucose level at 3\~4 h after infusion (mmol/L)202 (2 RCTs)LOW ^2,3^\--**MD0.99 fewer(1.61 fewer to 0.36 fewer)**Blood glucose level at 6h after infusion (mmol/L)70 (1 RCT)LOW ^4,5^\--MD 0.62 fewer(1.86 fewer to 0.61 more)Insulin level at 1.5 h after infusion (mU/L)132 (1 RCT)LOW ^2,4^-**MD13.5 fewer(19.02 fewer to 7.98 fewer)**Insulin level at 3 h after infusion (mU/L)132 (1 RCT)LOW ^2,4^-**MD8.59 fewer(13.75 fewer to 3.43 fewer)**Blood uric acid level at 3 h after infusion (μmol/L)132 (1 RCT)LOW ^4,5^-MD 8 fewer(34.96 fewer to 18.96 more)Positive rate of urine carcass202 (2 RCTs)LOW ^3,5^OR 1.14(0.49 to 2.64)129 per 1,00015 more per 1,000(61 fewer to 152 more)Positive rate of urine glucose70 (1 RCT)LOW ^1,5^RR 0.21(0.01 to 4.25)56 per 1,00044 fewer per 1,000(55 fewer to 181 more)PCEA VS PCIABlood glucose level at 3 h after the onset of analgesia (mmol/L)33 (1 RCT)LOW ^1,5^\--MD 0.01 more(0.21 fewer to 0.23 more)Blood glucose level at 3 h after the onset of analgesia (mmol/L)33 (1 RCT)LOW ^1,2^\--**MD0.8 fewer(1.01 fewer to 0.59 fewer)**Blood glucose level at 12h after the onset of analgesia (mmol/L)33 (1 RCT)LOW ^1,2^\--**MD0.76 fewer(1 fewer to 0.52 fewer)**Blood glucose level at 24h after the onset of analgesia (mmol/L)33 (1 RCT)LOW ^1,2^-**MD0.65 fewer(0.87 fewer to 0.43 fewer)**Blood glucose level at 36h after the onset of analgesia (mmol/L)33 (1 RCT)LOW ^1,2^\--**MD0.75 fewer(0.96 fewer to 0.54 fewer)**VAS score at 36h after the onset of analgesia (mmol/L)33 (1 RCT)LOW ^1,5^\--MD 0.04 fewer(0.31 fewer to 0.23 more)VAS score at 6h after the onset of analgesia (mmol/L)33 (1 RCT)LOW ^1,5^-MD 0.01 fewer(0.2 fewer to 0.18 more)VAS score at 12h after the onset of analgesia (mmol/L)33 (1 RCT)LOW ^1,5^-MD 0.02 fewer(0.24 fewer to 0.2 more)VAS score at 24h after the onset of analgesia (mmol/L)33 (1 RCT)LOW ^1,5^-MD 0.05 fewer(0.39 fewer to 0.29 more)VAS score at 36h after the onset of analgesia (mmol/L)33 (1 RCT)LOW ^1,5^-MD 0.04 fewer(0.35 fewer to 0.27 more)Satisfaction rate of analgesic effect33 (1 RCT)LOW ^1,5^RR 1.00(0.89 to 1.12)1,000 per 1,000**0** fewer per 1,000(110 fewer to 120 more)Vausea and vomiting33 (1 RCT)LOW ^1,5^RR 0.31(0.01 to 7.21)63 per 1,00043 fewer per 1,000(62 fewer to 388 more)Uroschesis33 (1 RCT)LOW ^1,5^RR 2.83(0.12 to 64.89)\--Postoperative wound care: microwave treatment of VS routine careWound healing rate at first stage140 (1 RCT)LOW ^1,2^**RR 1.15(1.03 to 1.29)**843 per 1,000**126 more per 1,000(25 more to 244 more)**Psychological intervention (including music therapy) VS routine careSystolic pressure immediately into the operating room (mmHg)200 (1 RCT)LOW ^2,6^\--**MD9.8 fewer(12.42 fewer to 7.18 fewer)**Systolic pressure after surgery into the operating room 30min (mmHg)200 (1 RCT)LOW ^2,6^\--**MD35.37 fewer(38.32 fewer to 32.42 fewer)**Intraoperative systolic pressure (mmHg)153 (1 RCT)LOW ^2,6^\--**MD22.63 fewer(27.24 fewer to 18.02 fewer)**Diastolic pressure immediately into the operating room (mmHg)200 (1 RCT)LOW ^2,6^\--**MD3.58 fewer(5.2 fewer to 1.96 fewer)**Diastolic pressure after surgery into the operating room 30min (mmHg)200 (1 RCT)LOW ^2,6^\--**MD7.58 fewer(9.62 fewer to 5.54 fewer)**Intraoperative diastolic pressure (mmHg)153 (1 RCT)LOW ^2,6^\--**MD10.61 fewer(14.65 fewer to 6.57 fewer)**Heart rate immediately into the operating room200 (1 RCT)LOW ^5,6^\--MD 0.86 fewer(2.69 fewer to 0.97 more)Heart rate after surgery into the operating room 30min200 (1 RCT)LOW ^2,6^\--**MD8.89 fewer(10.52 fewer to 7.26 fewer)**Anxiety score immediately into the operating room200 (1 RCT)LOW ^5,6^\--MD 0.13 fewer(2.57 fewer to 2.31 more)Anxiety score after surgery into the operating room 30min200 (1 RCT)LOW ^2,6^\--**MD2.22 fewer(3.55 fewer to 0.89 fewer)**Intro-operative hemorrhage (ml)153 (1 RCT)LOW ^2,6^\--**MD62.39 fewer(78.31 fewer to 46.47 fewer)**Postoperative pains153 (1 RCT)LOW ^2,6^**RR 0.73(0.60 to 0.89)**855 per 1,000**231 fewer per 1,000(342 fewer to 94 fewer)**Postoperative normal feeding153 (1 RCT)LOW ^5,6^RR 1.07(0.99 to 1.16)908 per 1,00064 more per 1,000(9 fewer to 145 more)Postoperative morbidity153 (1 RCT)LOW ^2,6^**RR 0.35(0.19 to 0.64)**408 per 1,000**265 fewer per 1,000(330 fewer to 147 fewer)**Epidural anesthesia vs general anesthesiaBlood glucose while skin cutting (mmol/L)54 (1 RCT)LOW ^1,2^\--**MD1.48 higher(1.31 higher to 1.56 higher)**Blood glucose while delivery of the fetus (mmol/L)54 (1 RCT)LOW ^1,5^\--MD **0** (0.17 lower to 0.17 higher)Blood glucose while delivery of placenta(mmol/L)54 (1 RCT)LOW ^1,2^\--**MD0.19 fewer(0.37 fewer to 0.1 fewer)**Blood glucose about 2 hours after delivery of the fetus (mmol/L)54 (1 RCT)LOW ^1,2^\--**MD0.9 higher(0.71 higher to 1.09 higher)**Blood glucose about 6 hours after delivery of the fetus (mmol/L)54 (1 RCT)LOW ^1,2^\--**MD1.11 higher(0.93 higher to 1.29 higher)**Apgar scores \<754 (1 RCT)LOW ^1,5^RR 0.20(0.01 to 3.98)\--Combined spinal and epidural analgesia: low dose sufentanil combined with bupivacaine VS bupivacaineBlood glucose while skin cutting (mmol/L)66 (1 RCT)LOW ^1,2^\--**MD1.45 fewer(1.61 fewer to 1.29 fewer)**Blood glucose while delivery of the fetus (mmol/L)66 (1 RCT)LOW ^1,5^\--MD 0.01 more(0.13 fewer to 0.15 more)Blood glucose about 5min after delivery of placenta (mmol/L)66 (1 RCT)LOW ^1,2^\--**MD0.23 more(0.06 more to 0.4 more)**Blood glucose about 2 hours after delivery of the fetus (mmol/L)66 (1 RCT)LOW ^1,2^\--**MD0.89 fewer(1.07 fewer to 0.71 fewer)**Mean arterial pressure at 1min after anesthesia (mmHg)66 (1 RCT)LOW ^1,5^\--MD 0.4 more(2.11 fewer to 2.91 more)Mean arterial pressure at 2min after anesthesia (mmHg)66 (1 RCT)LOW ^1,5^\--MD 1.4 more(1.62 fewer to 4.42 more)Mean arterial pressure at 5min after anesthesia (mmHg)66 (1 RCT)LOW ^1,2^\--**MD5.8 more(3.12 more to 8.48 more)**Mean arterial pressure at 10min after anesthesia (mmHg)66 (1 RCT)LOW ^1,5^\--MD 0.3 more(2.47 fewer to 3.07 more)Mean arterial pressure at 20min after anesthesia (mmHg)66 (1 RCT)LOW ^1,5^\--MD 1.9 more(1.1 fewer to 4.9 more)Apgar score at 1min66 (1 RCT)LOW ^1,5^\--MD 0.1 more(0.17 fewer to 0.37 more)Apgar score at 5mins66 (1 RCT)LOW ^1,2^\--**MD0.1 more(0.02 more to 0.18 more)**Additional an antibiotic once vs 24 hours antibiotic applicationMarked effective rate120 (1 RCT)LOW ^1,2^**RR 0.68(0.48 to 0.97)**633 per 1,000**203 fewer per 1,000(329 fewer to 19 fewer)**Effective rate120 (1 RCT)LOW ^1,5^RR 1.50(0.97 to 2.33)333 per 1,000167 more per 1,000(10 fewer to 443 more)Inefficient rate120 (1 RCT)LOW ^1,5^RR 2.00(0.38 to 10.51)33 per 1,00033 more per 1,000(21 fewer to 317 more)Total effective rate120 (1 RCT)LOW ^1,5^RR 0.97(0.89 to 1.05)967 per 1,00029 fewer per 1,000(106 fewer to 48 more)WBC\<12×10^9^/L time (d)120 (1 RCT)LOW ^1,5^\--MD 0.50 more(0.02 fewer to 1.02 more)Body temperature (no fever and return to normal 48 h after surgery)120 (1 RCT)LOW ^1,5^RR 0.98(0.93 to 1.04)983 per 1,00020 fewer per 1,000(69 fewer to 39 more)Class-A healing rate120 (1 RCT)LOW ^1,5^RR 0.97(0.89 to 1.05)967 per 1,00029 fewer per 1,000(106 fewer to 48 more)Class-B healing rate120 (1 RCT)LOW ^1,5^RR 2.00(0.38 to 10.51)33 per 1,00033 more per 1,000(21 fewer to 317 more)Class-C healing rate120 (1 RCT)\-\-\--\*The risk in the intervention group (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).**GRADE Working Group grades of evidence: high quality**: we are very confident that the true effect lies close to that of the estimate of the effect. **Moderate quality**: we are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. **Low quality**: our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect. **Very low quality**: we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect[^5]**Abbreviation:** MD, mean difference.

[^1]: These authors contributed equally to this work

[^2]: **Notes:** ○: Unreported; ●: reported; ^a^Liaoning Natural Science Foundation Project (20042089), Liaoning Education Department Fund Project (20062013); ^b^Science and Technology Research and Development Plan of Hebei province(132777208).

[^3]: **Abbreviation:** PCEA, patient-controlled epidural analgesia.

[^4]: **Notes:** Bold values indicate statistical significance if the interval does not cross zero for continuous outcomes with MD , and cross one for dichotomous outcomes with RR. The bold values also mean the effect or difference was statistically significant.

    **Abbreviation:** MD, mean difference.

[^5]: **Notes:**^1^No random sequences were reported to generate and assign hidden methods, and no blindness was given to researchers, subjects, and outcome evaluators. ^2^The sample size is less than the optimal information sample size. ^3^None of the studies reported randomized generation and allocation of hidden methods, one of which did not blind the researchers and subjects. ^4^The method of generating and assigning hidden random numbers is not reported. ^5^The sample size is less than the optimal information sample size, and the confidence interval of the combined effect is across the invalid line. ^6^No evaluation of the outcome of the blind. The bold values mean the effect or difference was statistically significant.
